ArticleScientific reports2025

Circulating biomarkers in patients with progressive fibrosing interstitial lung disease treated with nintedanib: a pilot study.

Vitale Miceli et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.